Peritoneal Dialysis Use and Practice Patterns : An International Survey Study
Crown Copyright © 2020. Published by Elsevier Inc. All rights reserved..
RATIONALE & OBJECTIVE: Approximately 11% of people with kidney failure worldwide are treated with peritoneal dialysis (PD). This study examined PD use and practice patterns across the globe.
STUDY DESIGN: A cross-sectional survey.
SETTING & PARTICIPANTS: Stakeholders including clinicians, policy makers, and patient representatives in 182 countries convened by the International Society of Nephrology between July and September 2018.
OUTCOMES: PD use, availability, accessibility, affordability, delivery, and reporting of quality outcome measures.
ANALYTICAL APPROACH: Descriptive statistics.
RESULTS: Responses were received from 88% (n=160) of countries and there were 313 participants (257 nephrologists [82%], 22 non-nephrologist physicians [7%], 6 other health professionals [2%], 17 administrators/policy makers/civil servants [5%], and 11 others [4%]). 85% (n=156) of countries responded to questions about PD. Median PD use was 38.1 per million population. PD was not available in 30 of the 156 (19%) countries responding to PD-related questions, particularly in countries in Africa (20/41) and low-income countries (15/22). In 69% of countries, PD was the initial dialysis modality for≤10% of patients with newly diagnosed kidney failure. Patients receiving PD were expected to pay 1% to 25% of treatment costs, and higher (>75%) copayments (out-of-pocket expenses incurred by patients) were more common in South Asia and low-income countries. Average exchange volumes were adequate (defined as 3-4 exchanges per day or the equivalent for automated PD) in 72% of countries. PD quality outcome monitoring and reporting were variable. Most countries did not measure patient-reported PD outcomes.
LIMITATIONS: Low responses from policy makers; limited ability to provide more in-depth explanations underpinning outcomes from each country due to lack of granular data; lack of objective data.
CONCLUSIONS: Large inter- and intraregional disparities exist in PD availability, accessibility, affordability, delivery, and reporting of quality outcome measures around the world, with the greatest gaps observed in Africa and South Asia.
| Errataetall: |
CommentIn: Am J Kidney Dis. 2021 Mar;77(3):309-311. - PMID 33334628 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:77 |
|---|---|
| Enthalten in: |
American journal of kidney diseases : the official journal of the National Kidney Foundation - 77(2021), 3 vom: 01. März, Seite 315-325 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 22.03.2021 Date Revised 22.03.2021 published: Print-Electronic CommentIn: Am J Kidney Dis. 2021 Mar;77(3):309-311. - PMID 33334628 Citation Status MEDLINE |
|---|
| doi: |
10.1053/j.ajkd.2020.05.032 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM313754578 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM313754578 | ||
| 003 | DE-627 | ||
| 005 | 20231225151242.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1053/j.ajkd.2020.05.032 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1045.xml |
| 035 | |a (DE-627)NLM313754578 | ||
| 035 | |a (NLM)32800844 | ||
| 035 | |a (PII)S0272-6386(20)30891-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cho, Yeoungjee |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Peritoneal Dialysis Use and Practice Patterns |b An International Survey Study |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.03.2021 | ||
| 500 | |a Date Revised 22.03.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Am J Kidney Dis. 2021 Mar;77(3):309-311. - PMID 33334628 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Crown Copyright © 2020. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a RATIONALE & OBJECTIVE: Approximately 11% of people with kidney failure worldwide are treated with peritoneal dialysis (PD). This study examined PD use and practice patterns across the globe | ||
| 520 | |a STUDY DESIGN: A cross-sectional survey | ||
| 520 | |a SETTING & PARTICIPANTS: Stakeholders including clinicians, policy makers, and patient representatives in 182 countries convened by the International Society of Nephrology between July and September 2018 | ||
| 520 | |a OUTCOMES: PD use, availability, accessibility, affordability, delivery, and reporting of quality outcome measures | ||
| 520 | |a ANALYTICAL APPROACH: Descriptive statistics | ||
| 520 | |a RESULTS: Responses were received from 88% (n=160) of countries and there were 313 participants (257 nephrologists [82%], 22 non-nephrologist physicians [7%], 6 other health professionals [2%], 17 administrators/policy makers/civil servants [5%], and 11 others [4%]). 85% (n=156) of countries responded to questions about PD. Median PD use was 38.1 per million population. PD was not available in 30 of the 156 (19%) countries responding to PD-related questions, particularly in countries in Africa (20/41) and low-income countries (15/22). In 69% of countries, PD was the initial dialysis modality for≤10% of patients with newly diagnosed kidney failure. Patients receiving PD were expected to pay 1% to 25% of treatment costs, and higher (>75%) copayments (out-of-pocket expenses incurred by patients) were more common in South Asia and low-income countries. Average exchange volumes were adequate (defined as 3-4 exchanges per day or the equivalent for automated PD) in 72% of countries. PD quality outcome monitoring and reporting were variable. Most countries did not measure patient-reported PD outcomes | ||
| 520 | |a LIMITATIONS: Low responses from policy makers; limited ability to provide more in-depth explanations underpinning outcomes from each country due to lack of granular data; lack of objective data | ||
| 520 | |a CONCLUSIONS: Large inter- and intraregional disparities exist in PD availability, accessibility, affordability, delivery, and reporting of quality outcome measures around the world, with the greatest gaps observed in Africa and South Asia | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Epidemiology | |
| 650 | 4 | |a RRT modality | |
| 650 | 4 | |a access to health care | |
| 650 | 4 | |a affordability of health care | |
| 650 | 4 | |a end-stage renal disease (ESRD) | |
| 650 | 4 | |a global survey | |
| 650 | 4 | |a health care delivery | |
| 650 | 4 | |a health care disparities | |
| 650 | 4 | |a health policy | |
| 650 | 4 | |a home dialysis | |
| 650 | 4 | |a international differences | |
| 650 | 4 | |a kidney failure | |
| 650 | 4 | |a peritoneal dialysis (PD) | |
| 650 | 4 | |a renal replacement therapy (RRT) | |
| 700 | 1 | |a Bello, Aminu K |e verfasserin |4 aut | |
| 700 | 1 | |a Levin, Adeera |e verfasserin |4 aut | |
| 700 | 1 | |a Lunney, Meaghan |e verfasserin |4 aut | |
| 700 | 1 | |a Osman, Mohamed A |e verfasserin |4 aut | |
| 700 | 1 | |a Ye, Feng |e verfasserin |4 aut | |
| 700 | 1 | |a Ashuntantang, Gloria E |e verfasserin |4 aut | |
| 700 | 1 | |a Bellorin-Font, Ezequiel |e verfasserin |4 aut | |
| 700 | 1 | |a Gharbi, Mohammed Benghanem |e verfasserin |4 aut | |
| 700 | 1 | |a Davison, Sara N |e verfasserin |4 aut | |
| 700 | 1 | |a Ghnaimat, Mohammad |e verfasserin |4 aut | |
| 700 | 1 | |a Harden, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Htay, Htay |e verfasserin |4 aut | |
| 700 | 1 | |a Jha, Vivekanand |e verfasserin |4 aut | |
| 700 | 1 | |a Kalantar-Zadeh, Kamyar |e verfasserin |4 aut | |
| 700 | 1 | |a Kerr, Peter G |e verfasserin |4 aut | |
| 700 | 1 | |a Klarenbach, Scott |e verfasserin |4 aut | |
| 700 | 1 | |a Kovesdy, Csaba P |e verfasserin |4 aut | |
| 700 | 1 | |a Luyckx, Valerie |e verfasserin |4 aut | |
| 700 | 1 | |a Neuen, Brendon |e verfasserin |4 aut | |
| 700 | 1 | |a O'Donoghue, Donal |e verfasserin |4 aut | |
| 700 | 1 | |a Ossareh, Shahrzad |e verfasserin |4 aut | |
| 700 | 1 | |a Perl, Jeffrey |e verfasserin |4 aut | |
| 700 | 1 | |a Rashid, Harun Ur |e verfasserin |4 aut | |
| 700 | 1 | |a Rondeau, Eric |e verfasserin |4 aut | |
| 700 | 1 | |a See, Emily J |e verfasserin |4 aut | |
| 700 | 1 | |a Saad, Syed |e verfasserin |4 aut | |
| 700 | 1 | |a Sola, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Tchokhonelidze, Irma |e verfasserin |4 aut | |
| 700 | 1 | |a Tesar, Vladimir |e verfasserin |4 aut | |
| 700 | 1 | |a Tungsanga, Kriang |e verfasserin |4 aut | |
| 700 | 1 | |a Kazancioglu, Rumeyza Turan |e verfasserin |4 aut | |
| 700 | 1 | |a Yee-Moon Wang, Angela |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Chih-Wei |e verfasserin |4 aut | |
| 700 | 1 | |a Zemchenkov, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Ming-Hui |e verfasserin |4 aut | |
| 700 | 1 | |a Jager, Kitty J |e verfasserin |4 aut | |
| 700 | 1 | |a Caskey, Fergus J |e verfasserin |4 aut | |
| 700 | 1 | |a Jindal, Kailash K |e verfasserin |4 aut | |
| 700 | 1 | |a Okpechi, Ikechi G |e verfasserin |4 aut | |
| 700 | 1 | |a Tonelli, Marcello |e verfasserin |4 aut | |
| 700 | 1 | |a Harris, David C |e verfasserin |4 aut | |
| 700 | 1 | |a Johnson, David W |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of kidney diseases : the official journal of the National Kidney Foundation |d 1982 |g 77(2021), 3 vom: 01. März, Seite 315-325 |w (DE-627)NLM012600814 |x 1523-6838 |7 nnns |
| 773 | 1 | 8 | |g volume:77 |g year:2021 |g number:3 |g day:01 |g month:03 |g pages:315-325 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1053/j.ajkd.2020.05.032 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 77 |j 2021 |e 3 |b 01 |c 03 |h 315-325 | ||